Sterol-regulatory-element-binding protein 1c is one member of the family of transcription factors that stimulate sterol and fatty-acid biosynthesis in animal cells. Human SREBP-1c, mapped to chromosome 17p11.2, is expressed in liver, intestine, skeletal muscle and adipocytes. A section of genomic sequence from a chromosome 17 library, thought to contain the SREBP-1c promoter, was cloned. Putative transcriptionfactor-binding sites and a potential transcriptional start site were identified using the Genomatix Suite of sequence analysis tools (MatInspector R ). Sequence analysis showed the human promoter to be 42% identical with the previously published mouse sequence. Two novel transcription-factor-binding sites were identified: those for PDX-1 (pancreatic-duodenal homoeobox-1) and HNF-4 (hepatic nuclear factor-4). Co-transfection experiments with overexpression plasmids for PDX-1 and HNF-4 suggested that both factors stimulate SREBP-1c gene expression, although further work is required to ascertain their mechanisms of action.
Introduction
Sterol-regulatory-element-binding proteins (SREBPs) are unique members of the basic helix-loop-helix leucine-zipper family of transcription factors. There are three isoforms of SREBPs, with SREBP-1c directly regulating lipid homoeostasis by activating lipogenic genes, including those encoding fatty acid synthase and acetyl-CoA carboxylase, which are involved in the production of palmitate [1, 2] . SREBPs are tripartite proteins synthesized as membrane-bound precursors in the endoplasmic reticulum. In times of sterol depletion, SREBP-cleavage-activating protein (SCAP) binds to the N-terminal domain of SREBP in a tight complex. SCAP chaperones SREBP in this complex to the Golgi apparatus, where SREBP is cleaved into its mature form by two site-specific proteases [3] . The transcriptionally active N-terminal domain then translocates to the nucleus, where it binds to sterol response elements (SREs) in the promoters of target genes. Transcriptional regulation of the mouse promoter has previously been described; however, little is known about regulation of the human SREBP-1c gene at the transcriptional level. thought to contain the human promoter was subcloned into pBluescript-KS plasmid (Promega). Sequence analysis was performed using Transfac R and MatInspector R software. For promoter analysis studies, this section was subcloned further into pGL3-Basic expression vector (Promega).
Materials and methods

Cell culture and transfections
McARH-7777 cells (American Type Tissue Collection) were maintained in a monolayer at 37
• C (5% CO 2 ) in DMEM (Dulbecco's modified Eagle's medium, low glucose; obtained from Sigma) supplemented with 10% (v/v) FCS (fetal-calf serum; Sigma). The cells were transfected using polyethyleneimine (PEI), yielding an approximate 10:1 PEI/DNA charge ratio. Cells were incubated with the appropriate treatments in serum-free medium for 6 h and harvested after a further 36 h incubation. Firefly luciferase activity was assayed on cell lysates and expressed as relative light units (RLU)/mg of protein.
Results
Sequence alignments show that the human SREBP-1c promoter sequence is 42.0% identical with the mouse promoter, suggesting that the promoters may be regulated by different pathways and mechanisms. We identified 59 putative transcription-factor-binding sites [4, 5] . These included sites for SRE, SP-1 (stimulating protein-1), NF-Y (nuclear factor Y) and LXRE (liver X receptor response element), all of which are present in the mouse promoter (Figure 1 ). In addition, two further response elements for HNF-4 (hepatic nuclear factor-4) and PDX-1 (pancreatic-duodenal homoeobox-1) were present in the human promoter, but not in the mouse promoter sequence. HNF-4 is a liver-specific transcription factor, and the α2 isoform is expressed at greater levels in liver cells than the α1 isoform [6] . PDX-1 is a transcription factor expressed in pancreatic β and δ cells, and plays a crucial role in linking β-cell glucose metabolism and insulin secretion. Luciferase reporter assays were carried out in McA-RH7777 rat hepatoma cells to investigate the response of the human SREBP-1c promoter to transcription factors and external stimuli. As with the mouse promoter, insulin stimulated (20-fold) and polyunsaturated fatty acids decreased (0.5-fold) human promoter activity. Co-transfection with overexpression vectors for LXR-α and RXR-α (retinoid X receptor-α) also stimulated transcription 7-fold. Figure 2 demonstrates the effects seen with overexpression vectors for HNF-4 α1, HNF-4 α2 and PDX-1 on human SREBP-1c promoter activity. All three stimulated the transcription rate, with maximal activity occurring at 300 ng of HNF-4 α1, 30 ng of HNF-4 α2 and 300 ng of PDX-1. HNF-4 α1 increased expression by approx. 50%, whereas the α2 isoform caused a 3-fold enhancement in promoter activity. PDX-1 caused a 3.5-fold increase in expression.
Concluding remarks
Although the human and mouse SREBP-1c promoter sequences share conserved elements in the SRE complex, such as the SRE, LXRE and NF-Y sites, clearly the two sequences are very different (42.0% similar), suggesting that they may not be regulated in the same manner. This is supported by the presence of different response elements in the human promoter, which were identified using transcription factor databases.
Initial transient transfections show SREBP-1c to be positively regulated by PDX-1 and HNF-4. Mutational studies will determine whether these responses are due to direct interactions of the transcription factors with the sites identified in the human SREBP-1c promoter. SREBP-1c is expressed in a variety of tissues, including liver, adipose tissue, pancreatic β-cells, intestine and skeletal muscle. As HNF-4 expression is largely restricted to the liver and intestine, and PDX-1 is only expressed in β-cells, it is possible that these novel response elements may be involved in tissue-specific regulation of human SREBP-1c.
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